This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Take the Zacks Approach to Beat the Markets: Hecla Mining, GE Aerospace & Stride in Focus
by Santanu Roy
Zacks highlights Hecla Mining, GE Aerospace, and Stride as standout performers in a volatile market, driven by earnings trends and stock upgrades.
GEPositive Net Change JNJNegative Net Change HDPositive Net Change SENegative Net Change AZOPositive Net Change MTDNegative Net Change HLPositive Net Change LRNPositive Net Change KARPositive Net Change SHOPNegative Net Change NOBLPositive Net Change SHLSNegative Net Change
aerospace alt-energy auto-tires-trucks computers consumer-discretionary internet medical-devices pharmaceuticals retail
PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
by Zacks Equity Research
PacBio collaborates with EpiCypher to integrate Fiber-Seq and HiFi sequencing, advancing single-molecule epigenomics with new chromatin mapping tools.
BSXPositive Net Change WSTNegative Net Change PACBNegative Net Change MEDPNegative Net Change
medical medical-devices
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G
by Zacks Equity Research
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
ABTPositive Net Change MDTPositive Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
Here's Why You Should Hold Cencora Stock in Your Portfolio Now
by Zacks Equity Research
COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.
BSXPositive Net Change CORPositive Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL's strong Q2 results, innovation pipeline, and high-tech growth drivers support its long-term expansion despite macro headwinds.
BSXPositive Net Change ECLPositive Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
by Urmimala Biswas
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
HALONegative Net Change LDOSPositive Net Change PAHCPositive Net Change PDDNegative Net Change
medical medical-devices retail tech-stocks
Is it the Right Time to Add CRL Stock to Your Portfolio Now?
by Zacks Equity Research
Charles River's DSA growth, acquisitions and collaborations support momentum, but forex and macro headwinds weigh on its outlook.
MASINegative Net Change CRLNegative Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
by Moumi Mondal
HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.
ABTPositive Net Change TMOPositive Net Change HOLXNegative Net Change
medical medical-devices
New Strong Buy Stocks for September 4th
by Zacks Equity Research
LRN, RL, ATRO, MASI and BYD have been added to the Zacks Rank #1 (Strong Buy) List on September 4, 2025.
MASINegative Net Change RLPositive Net Change ATRONegative Net Change BYDPositive Net Change LRNPositive Net Change
aerospace consumer-discretionary medical-devices
HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
HQY's Q2 results reflect EPS growth of 25.6% year over year, revenue growth of 8.6% and a 12% increase in HSA. The company also updates its fiscal 2026 guidance.
BSXPositive Net Change WSTNegative Net Change HQYPositive Net Change MEDPNegative Net Change
earnings medical medical-devices
Do Options Traders Know Something About InMode Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to InMode stock based on the movements in the options market lately.
INMDPositive Net Change
medical medical-devices
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
CLYMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
MongoDB (MDB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
MDBPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise
by Zacks Equity Research
QGEN announces the launch of FDA-cleared QIAstat-Dx Rise, which may boost U.S. diagnostic access and testing capacity worldwide.
MASINegative Net Change QGENPositive Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep
by Zacks Equity Research
Stereotaxis debuts MAGiC Sweep, the first U.S. robotic HD mapping catheter, marking a breakthrough in cardiac arrhythmia diagnosis and treatment.
BSXPositive Net Change STXSPositive Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?
by Indrajit Bandyopadhyay
Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.
MDTPositive Net Change ISRGPositive Net Change STXSPositive Net Change
medical medical-devices
IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
by Zacks Equity Research
iRhythm's AMALFI trial shows its Zio monitoring service boosts AF detection and speeds diagnosis, strengthening its edge in cardiac care.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change IRTCNegative Net Change
medical medical-devices
HIMS' Personalized Wellness Platform Expands Preventive Care Access
by Debanjana Dey
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
MEDPositive Net Change HIMSNegative Net Change DOCSNegative Net Change
medical medical-devices
Do Options Traders Know Something About Alcon Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ALC stock based on the movements in the options market lately.
ALCNegative Net Change
medical medical-devices
3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI
by Urmimala Biswas
Teleflex, Integer Holdings and Inogen are defying tariff and supply chain headwinds with genAI-driven momentum within the Medical Instruments industry.
TFXPositive Net Change INGNNegative Net Change ITGRPositive Net Change
artificial-intelligence medical medical-devices smart-health
Glaukos Builds Dual Growth Engines Amid Market Headwinds
by Zacks Equity Research
GKOS raises revenue guidance after record 1H sales, fueled by iDose TR adoption and expanding international glaucoma momentum.
JNJNegative Net Change ALCNegative Net Change GKOSPositive Net Change SGHTPositive Net Change
medical medical-devices
DuPont de Nemours (DD) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
DDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Vitesse Energy (VTS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VTSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Citizens Community Bancorp, Inc. (CZWI) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CZWINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
American Axle & Manufacturing (AXL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AXLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines